PortfoliosLab logoPortfoliosLab logo
ISIN
US58470H1014
CUSIP
58470H101
IPO Date
Dec 31, 1993

Highlights

Market Cap
$121.29M
Enterprise Value
$69.78M
EPS (TTM)
-$1.82
Total Revenue (TTM)
$346.10M
Gross Profit (TTM)
$242.70M
EBITDA (TTM)
-$3.86M
Year Range
$9.22 - $15.46
Target Price
$12.00
ROA (TTM)
-7.94%
ROE (TTM)
-10.13%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

MED Performance Chart

Medifast, Inc. (MED) is up 3.2% since the beginning of the year. At $11 per share, MED is trading 28.7% below its 52-week high of $15. Investors who bought $1,000 worth of MED shares 5 years ago would now be looking at an investment worth $44.


Loading charts...

S&P 500 Index

Returns By Period

Medifast, Inc. (MED) has returned 3.18% so far this year and -22.01% over the past 12 months. Over the last ten years, MED has returned -7.79% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Medifast, Inc.

1D
-0.18%
1M
-12.47%
YTD
3.18%
6M
-2.74%
1Y
-22.01%
3Y*
-49.36%
5Y*
-46.41%
10Y*
-7.79%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MED Monthly Returns History

Based on dividend-adjusted daily data since Dec 31, 1993, MED's average daily return is +0.26%, while the average monthly return is +2.70%. At this rate, an investment would double in approximately 2.2 years.

Historically, 46% of months were positive and 54% were negative. The best month was Jan 2000 with a return of +163.2%, while the worst month was Aug 1999 at -64.2%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.

On a daily basis, MED closed higher 43% of trading days. The best single day was Jun 6, 2000 with a return of +166.7%, while the worst single day was Dec 23, 1999 at -64.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20267.12%-7.95%-3.23%6.67%15.27%-12.05%3.18%
2025-10.90%-8.54%-6.13%-2.52%7.08%-0.14%-1.99%1.89%-2.57%-12.07%-8.74%-2.64%-39.39%
2024-18.70%-26.64%-4.42%-28.16%-6.50%-15.23%0.50%-16.55%4.59%-3.97%7.02%-10.42%-73.79%
2023-3.38%0.61%-5.95%-11.59%-14.13%19.33%10.56%-17.22%-9.41%-7.60%-4.02%1.27%-38.34%
2022-5.12%-6.40%-7.29%4.44%-6.51%9.19%-6.83%-25.39%-12.44%7.96%7.74%-7.19%-42.31%
202119.52%7.81%-15.74%7.21%46.31%-14.37%0.89%-20.18%-14.92%1.88%4.82%2.48%9.36%

Benchmark Metrics

Medifast, Inc. has an annualized alpha of 75.98%, beta of 0.75, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since December 31, 1993.

  • This stock participated in 94.33% of S&P 500 Index downside but only 69.91% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
75.98%
Beta
0.75
0.01
Upside Capture
69.91%
Downside Capture
94.33%

Return for Risk

Risk / Return Rank

MED ranks 19 for risk / return — in the bottom 19% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


MED Risk / Return Rank: 1919
Overall Rank
MED Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
MED Sortino Ratio Rank: 1717
Sortino Ratio Rank
MED Omega Ratio Rank: 1919
Omega Ratio Rank
MED Calmar Ratio Rank: 2020
Calmar Ratio Rank
MED Martin Ratio Rank: 2121
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Medifast, Inc. (MED) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MEDBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.56

Sortino ratioReturn per unit of downside risk

-3.40

Omega ratioGain probability vs. loss probability

0.93

1.37

-0.44

Calmar ratioReturn relative to maximum drawdown

-0.59

2.78

-3.38

Martin ratioReturn relative to average drawdown

-1.00

12.44

-13.44

Dividends

Dividend History

Medifast, Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%2.00%4.00%6.00%8.00%$0.00$1.00$2.00$3.00$4.00$5.00$6.00$7.0020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.00$0.00$0.00$4.95$6.56$5.68$4.52$3.38$2.19$1.44$1.07$0.25

Dividend yield

0.00%0.00%0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%

Monthly Dividends

The table displays the monthly dividend distributions for Medifast, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$1.65$0.00$0.00$1.65$0.00$0.00$1.65$0.00$0.00$0.00$4.95
2022$0.00$0.00$1.64$0.00$0.00$1.64$0.00$0.00$1.64$0.00$0.00$1.64$6.56
2021$0.00$0.00$1.42$0.00$0.00$1.42$0.00$0.00$1.42$0.00$0.00$1.42$5.68

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Medifast, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Medifast, Inc. was 98.40%, occurring on Dec 23, 1999. Recovery took 755 trading sessions.

The current Medifast, Inc. drawdown is 96.26%.


Related event

Drawdown

Fall

Recovery

Underwater

1999 bear market1999
-98.40%Dec 1999
5y 10mo3y 5d
8y 10moFeb 1994 - Dec 2002
2026 bear market2026
-96.76%Mar 2026
4y 9mo
5y 23dJun 2021 - now
2005 bear market2005
-85.56%Mar 2005
1y 3mo1y 3mo
2y 6moNov 2003 - Jun 2006
Financial crisis2007–2009
-83.16%Nov 2008
2y 5mo9mo 29d
3y 2moJun 2006 - Sep 2009
COVID crash2020
-78.91%Mar 2020
1y 6mo10mo 13d
2y 4moSep 2018 - Jan 2021

Drawdown Indicators


MEDBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-98.40%

-56.78%

-41.62%

Max Drawdown (1Y)

Largest decline over 1 year

-37.39%

-9.10%

-28.29%

Max Drawdown (3Y)

Largest decline over 3 years

-90.91%

-18.90%

-72.01%

Max Drawdown (5Y)

Largest decline over 5 years

-96.29%

-25.43%

-70.86%

Max Drawdown (10Y)

Largest decline over 10 years

-96.76%

-33.92%

-62.84%

Current Drawdown

Current decline from peak

-96.26%

-1.80%

-94.46%

Average Drawdown

Average peak-to-trough decline

-50.87%

-10.71%

-40.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.13%

2.03%

+20.10%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Medifast, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Medifast, Inc. is priced in the market compared to other companies in the Personal Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for MED relative to other companies in the Personal Services industry. Currently, MED has a P/S ratio of 0.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for MED in comparison with other companies in the Personal Services industry. Currently, MED has a P/B value of 0.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with MED

Add Medifast, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with MED